AbstractWe describe the development of cell-penetrating inhibitors of Ras and study their ability to inhibit T cell activation. The inhibitors transduced T cells in a time and concentration-dependent manner and interacted with endogenous Ras. Anti-CD3/CD28-activated cells when treated with the inhibitors, exhibited a notable reduction in cell size, diminished proliferative capacity, and were more prone to apoptosis. Similarly, lymphocytes activated by antigen in vivo, exhibited accelerated apoptosis when treated with the inhibitors ex vivo. Our data reveal a pro-survival role for Ras in activated primary T cells and describe a new methodology for regulating its activity.Structured summaryMINT-6802882: RAF1 (uniprotkb:P04049) physically inte...
Oncogenic Ras genes are activated by point mutation in about 30% of human tumours, being one of the ...
Clinically used RAF inhibitors are ineffective in RAS-mutant tumors because they enhance homo- and h...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
AbstractWe describe the development of cell-penetrating inhibitors of Ras and study their ability to...
AbstractT-cell receptor (TCR) triggering by an anti-CD3 antibody or phytohemagglutinin (PHA) as well...
Despite the fact that RAF-1 lies immediately downstream of p21RAS in the MAP kinase-signalling casca...
<p><b>A</b>. Purified C57BL/6 CD4<sup>+</sup> T cells were stimulated with anti-CD3 and anti-CD28 an...
In a Jurkat cell model of T-cell activation an interleukin-2 promoter/reporter gene construct was ac...
Ras signaling pathways play an important role in cellular proliferation and survival, and inappropri...
Both the T cell receptor for antigen, the TCR, which mediates T cell activation, and the receptor fo...
Tumor necrosis factor (TNF)-induced apoptosis is important in immunologic cytotoxicity, autoimmunity...
The GTPase, Ras, is rapidly activated in antigen receptor stimulated T cells, B cells and mast cells...
T cell activation is triggered by antigen stimulation and is characterized by the production of a wi...
CD28 is a 44-kD homodimer expressed on the surface of the majority of human T cells that provides an...
ABSTRACT THE ROLE OF p120 RasGAP IN T CELLS AND LYMPHATICS by Philip E. Lapinski Chair: ...
Oncogenic Ras genes are activated by point mutation in about 30% of human tumours, being one of the ...
Clinically used RAF inhibitors are ineffective in RAS-mutant tumors because they enhance homo- and h...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
AbstractWe describe the development of cell-penetrating inhibitors of Ras and study their ability to...
AbstractT-cell receptor (TCR) triggering by an anti-CD3 antibody or phytohemagglutinin (PHA) as well...
Despite the fact that RAF-1 lies immediately downstream of p21RAS in the MAP kinase-signalling casca...
<p><b>A</b>. Purified C57BL/6 CD4<sup>+</sup> T cells were stimulated with anti-CD3 and anti-CD28 an...
In a Jurkat cell model of T-cell activation an interleukin-2 promoter/reporter gene construct was ac...
Ras signaling pathways play an important role in cellular proliferation and survival, and inappropri...
Both the T cell receptor for antigen, the TCR, which mediates T cell activation, and the receptor fo...
Tumor necrosis factor (TNF)-induced apoptosis is important in immunologic cytotoxicity, autoimmunity...
The GTPase, Ras, is rapidly activated in antigen receptor stimulated T cells, B cells and mast cells...
T cell activation is triggered by antigen stimulation and is characterized by the production of a wi...
CD28 is a 44-kD homodimer expressed on the surface of the majority of human T cells that provides an...
ABSTRACT THE ROLE OF p120 RasGAP IN T CELLS AND LYMPHATICS by Philip E. Lapinski Chair: ...
Oncogenic Ras genes are activated by point mutation in about 30% of human tumours, being one of the ...
Clinically used RAF inhibitors are ineffective in RAS-mutant tumors because they enhance homo- and h...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...